The effect and mechanism of ovarian cancer HO-8910 cell apoptosis induced by crocin.MTT assay was performed to detect the inhibitory action of crocin on the proliferation of HO-8910 cells. Flow cytometry was used to test the cell cycle distribution and apoptosis rate of ovarian cancer HO-8910 cells. Western blot analysis was utilized to measure the levels of apoptotic proteins such as p53, Fas/APO-1, and Caspase-3. MTT analysis revealed that crocin significantly inhibited the growth of HO-8910 cells. Additionally, flow cytometry illustrated that crocin raised the proportion of HO-8910 cells in the G 0 /G 1 phase and increased their apoptosis rate. Furthermore, Western blot analysis revealed that crocin up-regulated the expression of p53, Fas/APO-1, and Caspase-3.The results of this study showed that crocin can significantly inhibit the growth of HO-8910 cells and arrest them in the G 0 /G 1 phase. Crocin can also promote ovarian cancer HO-8910 cell apoptosis, most likely by increasing p53 and Fas/APO-1 expression, and then activating the apoptotic pathway regulated by Caspase-3.
Saffron also known as aurum vegetable, obtained from Crocus sativus L., family Iridaceae, is an effective medicine for accelerating blood circulation and dissipating blood stasis. Additionally, it is water-soluble and inhibits cancer cells. Consequently, it has the potential to be used in cancer treatment [1] . Crocin, a chemical component, is the main pigment of saffron crocus. Formed by glycosylation of crocetin, it is a rare watersoluble carotenoid [1] . Currently, a number of studies are focused on the effects of crocin on cervical carcinoma, carcinoma of the urinary bladder, leukemia, squamous cell carcinoma of the tongue, carcinoma of the colon, pancreatic cancer, and others [2] [3] [4] [5] [6] . It is believed that crocin can inhibit the survivin expression and cause apoptosis of the tumor cells by increasing Caspase-3 excision, while controlling the proportion of BCL-2/bax. Also, by inhibiting Cyclin D1 expression and increasing p27 kip1 protein expression, crocin can arrest the tumor cell cycle and inhibit tumor proliferation. Since crocin can increase the poisoning effect of cells through liposome encapsulation, it can potentially be used as a tumor preventive agent [7] . Crocin does not cause significant adverse reactions, and is an effective chemotherapeutic and prophylactic agent [8] . This study observed the effects of crocin on the apoptosis of ovarian cancer HO-8910 cells and investigated the mechanisms that cause the apoptosis for the purpose of clinical treatment of tumors.
The influence of crocin on the inhibition of HO-8910 cell proliferation:
Based on MTT analysis, different concentrations of crocin significantly increased the inhibitory rates of HO-8910 of HOC after 24 and 48 hours. There was a dependent relationship between reaction time and dosage. Crocin significantly inhibited HO-8910 cell growth (p < 0.05). There were statistically significant differences between different groups of concentrations and between the 24-and 48-hour reaction (p < 0.0001; Figure 1 ).
The influence of crocin on the period distribution of HO-8910 cells:
Based on the results of the flow cytometry test, with increasing concentrations of crocin and extensions of reaction times, the rates of cell population in the G 0 /G 1 period began to increase in the HO-8910 cells of HOC. There were statistically significant differences between the different concentrations of crocin and between the 24-and 48-hour reactions (p < 0.05). The HO-8910 cells of HOC were blocked by crocin in the G 0 /G 1 period (see Figure 2 ). There were statistically significant differences between the different concentrations of crocin and between the 24-hour reaction and the 48-hour reaction (p < 0.05).
Figure 3:
The forms of HO-8910 apoptosis that were induced by crocin.The apoptosis with DAPI appeared as a white-blue fluorescence. A. For crocrin (0 mmol/L), there was no significant difference between the majority of cells; however, some individual cells showed apoptosis. The cell nuclei of apoptotic cells were concentrated and were deeply colored. Some nucleus chromatins appeared as crescent forms and moved toward caryotheca (see arrow head). B. For crocin (1.0 mmol/L), the majority of cells showed apoptosis. The nuclei of apoptotic cells broke into corps ronds of different sizes and were circumvoluted by cytomembrane. The corps ronds are also called apoptotic bodies( ) see arrow head . 
The influence of crocin on HO-8910, p53, Fas/APO-1, and cleaved Caspase-3 protein expressions:
Based on the results of the Western blot tests, after crocin (0, 0.2, 0.4, 0.8, and 1.0 mmol/L) reacted with the HO-8910 of HOC for 48 hours, the protein bands Previous research discovered that crocin revealed an impressive ability to inhibit leukemia, carcinoma of the colon, carcinoma of the uterine cervix, transitional cell carcinoma of the bladder, and tongue squamous cell carcinoma. Meanwhile, there are almost no toxic effects on normal cells [2] [3] [4] [5] [6] [7] [8] . Gong [9] found that crocin significantly inhibited HeLa auxesis. By reacting with crocin, the cells of HeLa shrunk, and the amount of cytoplasm decreased. In addition, Hela cells showed nuclei pyknosis and cytoplasm vacuolization. The findings proved that crocin is able to cause HeLa apoptosis. Crocin can also promote apoptosis by increasing the excision of Caspase-3 in HeLa cells. Moreover, Ji et al. [10] discovered that crocin can inhibit BIU-87 auxesis of carcinoma of the urinary bladder. Crocin changes the periodic distribution of BIU-87 by reducing CyclinD1 protein expression and increasing p27 kip1 protein expression, and blocks the cells in the G 0 /G 1 period. Furthermore, Bakshi et al. [11] , using Kashmir saffron, observed the reaction between crocin and BxPC-3 cells of pancreatic cancer. They found that crocin induced apoptosis of BxPC-3 cell lines, and the cells were blocked in the G 1 period. Also, there was a dependent relationship between reaction times and dosages in the suppression of cell viability.
In this study, the reactions between crocin and HO-8910 of HOC were tested with MTT with different concentrations of crocin and a range of reaction times. The results showed that as the concentration of crocin increased and the reaction time was extended, the inhibitory rates of HO-8910 of HOC increased. There was a dependent relationship between dosages and reaction times. Crocin significantly inhibited HO-8910 auxesis of HOC. Thus, this result agrees with Gong's finding [9] .
This study also tested the influence of crocin in different concentrations on the cycle distribution of HO-8910 of HOC with flow cytometry after 24 and 48 hours. It was discovered that as the concentration of crocin increased and reaction time was extended, the number of cells increased in the G 0 /G 1 period. This shows that the HO-8910 cells of HOC were blocked in the G 0 /G 1 period. This result is consistent with Ji's finding [10] .
Furthermore, this study tested the influence of crocin in different concentrations on the apoptosis of HO-8910 of HOC with flow cytometry after 24 and 48 hours. It was found that as the concentration of crocin increased and reaction time was extended, the apoptosis rates of HO-8910 of HOC increased. This shows that crocin can induce apoptosis of HO-8910 of HOC. This result is consistent with Bakshi's finding [11] .
A tumor suppressor protein, p53, is vital for cell activity. It affects cell aging or apoptosis, blocks the cell cycle, cell damage, and DNA repair. Not only can p53 promote the repair and survival of damaged cells, it can also eliminate, through apoptosis, damaged cells that cannot be repaired. Previous research found that p53 regulates the protein of target gene expression. In addition, p53 blocks the tumor cell cycle and inhibits the hyperplasia of tumor cells by activating the cycle and by dependant kinase inhibitor, p21 waf1 . Protein p53 also induces the apoptosis of mitochondriamediated cells by activating other apoptotic proteins of BCL-2 (Bax, Puma, and Noxa), and promotes Fas/APO-1 expression, so it can induce the apoptosis of mediated cells of death receptors [12] .
Fas (APO-1, CD95, TNFRSF6) is a TNF receptor. It is a death receptor which mediates apoptosis through extracellular ligandbinding FasL. It is one of the regulatory networks of Let-7/p53/miR-34 [13] . Based on previous studies, p53 increases the Fas expression in order to activate Caspase-8. This process causes the complex formation of death receptors, the activation of Caspase-3, excision of PARP, and apoptosis [14] . Hau et al. [13] found that Fas was the target gene of p53; hence, when p53 increases Fas expression, Fas also regulates p53 activation.
Caspase-3 is a member of the caspase family and is an important executor of apoptosis. Caspase-3 is synthesized in cytoplasm and exists as an inactive proenzyme. When activated by the stimulation of apoptosis, it can reduce multiple protein substrates. Therefore, it plays a vital role in the process of apoptosis and is the key to regulating apoptosis cascade reactions [15] .
Based on the results of the Western blot test, it was proved that crocin can promote p53, Fas/APO-1, and Caspase-3 protein expressions. It was assumed that crocin activates Caspase-3 to regulate the apoptosis through an increase of p53 and Fas/APO-1 protein expressions, so it can promote the HO-8910 apoptosis of HOC. This study provides clinical evidence to support the claim that HOC can be treated with crocin. Also, the findings can provide a foundation for future research on the mechanism of crocin on the apoptosis of HOC cells. It is logical to consider that crocin can be used as a natural medicine to treat HOC.
Experimental
Cell culture: HO-8910 cell lines of HOC and CHO cell lines were cultured in RPMI 1640 medium that included 10% inactivated fetal bovine serum and the subculture. The subculture was controlled with 5% saturated humidity of CO 2 and kept at 37°C.
Determining the growth curve of the cells:
The HO-8910 and CHO cells were collected during the logarithmic growth phase, and made into single cell suspensions with a concentration of 3 × 10 5 counts/mL. The single cell suspension was then added to 24-well culture plates. The volume of each well was 1 mL. After 24 h, the medium was changed and various concentrations of crocin were added to the wells. However, the 5 empty negative controls only contained RPMI 1640 nutrient fluid. Cell numbers were counted two times for each well after 12, 24, 36, and 48 h, and the cellgrowth curves were drawn.
Testing the inhibitory rate of cell growth with MTT:
The HO-8910 and CHO cells were collected during the logarithmic growth phase, and made into a single cell suspension with a concentration of 1 × 10 5 counts/mL. The single cell suspension was then added to 96-well culture plates. The volume of each well was 200 uL. After 24 h, the medium was changed and various concentrations of crocin were added to the wells. However, the 5 empty negative controls only contained RPMI 1640 nutrient fluid. After 24 and 48 h, 20 μL MTT (5 mg/mL) was added to each well. Supernatant was absorbed after 4 h. To each well 100 μL DMSO was added and shaken for 10 min. The absorbance (A) at 570 nm was measured using an automatic ELISA reader. Also, the inhibitory rates of cell growth in different concentrations were calculated with the formula: [Inhibitory rate = (Average value of blanks-Average value of samples)/Average value of blanks]
Analyzing cell cycles and testing apoptosis rates with flow cytometry:
HO-8910 cells were collected during the logarithmic growth phase, and made into a single cell suspension with a concentration of 1 × 10 6 counts/mL. The single cell suspension was then added to 6-well culture plates. The concentration of the culture was the same as in the above process. After 48 h, the cells were collected and made into single cell suspensions after cleansing PBS. After being immobilized in 70% ice ethanol at 4°C for 12 h and coloring with the dye liquor containing ribonuclease and PI for 30 min, the single cell suspensions were tested by flow cytometry. HO-8910 cells were collected during the logarithmic growth phase, and made into a single cell suspension with a concentration of 1 × 10 6 counts/mL. The single cell suspension was vaccinated into 6well culture plates. The concentration of the culture was the same as in the above process. After 48 h, the cells were collected. When the cells were dyed by DAPI, the single cell suspension was analyzed by flow cytometry.
Testing p53, Fas/APO-1, and cleaved caspase--3 protein expressions with Western blot:
Crocin was added to HO-8910 of HOC cells at concentrations of 0, 0.2, 0.4, 0.8, and 1.0 mmol/L. After 48 h, the culture was terminated. The cells were treated with a digestive juice containing 0.25% pancreatin and 0.02% ethylene diamine tetraacetic acid (EDTA). Then, cleansing with PBS, splitting decomposition, centrifugation, collecting the supernatant, and cryopreservation (-80°C) were performed. Proteins were separated by SDS-PAGE gel and transferred to NC membranes. Also, mouse anti-human p53, Fas/APO-1, cleaved caspase-3, and monoclonal anti-β-actin antibody were applied to the cells after 8 h at room temperature. After 2 1/2 h reaction at room temperature, the second antibody was added. The luminous color was tested with an ECL kit, followed by darkroom film exposure and scanning. This process was repeated 3 times as an independent experiment. Statistical analysis: SPSS 15.0 software (Chicago, IL, USA) was used to analyze the data. The measurements were displayed as mean ± SEM. The dosages at different reaction times were analyzed with t-test. The dosages among multiple groups were analyzed with analysis of variance (ANOVA). The dosages between groups were analyzed with SNK-q test.
